ArticleThe oncologist2025

A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer.

Emiliano Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.